VN

Vasumathi Nadarajan Rijees

Active Director Director DIN 07480073
DIN 07480073 First appointment Mar 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Vasumathi Nadarajan Rijees

Data last updated:

Vasumathi Nadarajan Rijees is a Director at Citwal Pharmaceuticals Private Limited (since 2018). The company operates in Business Services.

DIN 07480073
Primary Designation Director
Industry Business Services
First Appointment 21 Mar 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Mar 20182018Active

Board colleagues of Vasumathi Nadarajan Rijees

Directorship timeline

Open interactive timeline →
Citwal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vasumathi Nadarajan Rijees

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasumathi Nadarajan Rijees

Vasumathi Nadarajan Rijees currently holds 1 directorship: Citwal Pharmaceuticals Private Limited (Director, since 21 Mar 2018).

Vasumathi Nadarajan Rijees was first appointed on 21 Mar 2018 as Director at Citwal Pharmaceuticals Private Limited.

The current boards of Vasumathi Nadarajan Rijees's companies include Navas Abdul Rehuman (Citwal Pharmaceuticals Private Limited), Pradeep Kumar Muraleedharannair (Citwal Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available